Get the App

Back Stocks profile

Stock analysis tool for investors

Torrent Pharmaceuticals Ltd.

NSE: TORNTPHARM | BSE:500420

₹2670.00 27.45 (1.04%) 1D

Pharmaceuticals & Biotechnology

Buy Sell
View detailed Technical chart

Open an Account with Bigul in 5 minutes

Performance

Today’s low

2642.50

Today’s High

2688.40

52W low

1598.40

52W High

2744.00

Open Price

2652.80

Prev. Close

1832.60

Volume

94592.00

Value

252560640.00

Fundamentals

Market Cap Cr

90364.90

Price to Earnings

60.50

Price to Book Value

14.60

Dividend Yield

1.10

PE to Growth

0.80

Op Revenue TTM Cr

10474.00

Net Profit TTM Cr

1494.00

Cash From Operating Activity Cr

2368.13

Return on Equity %

20.09

EMA & SMA

Bullish Moving Averages

15

Bearish Moving Averages

1

5Day EMA

2663.6

10Day EMA

2645.7

12Day EMA

2639.7

20Day EMA

2625.1

26Day EMA

2618.8

50Day EMA

2588.2

100Day EMA

2481

200Day EMA

2281.6

5Day SMA

2677.1

10Day SMA

2638.7

20Day SMA

2607.4

30Day SMA

2595.5

50Day SMA

2618.6

100Day SMA

2496.4

150Day SMA

2321.2

200Day SMA

2226.3

DELIVERY AND VOLUME

DAILY AVG. DELIVERY VOLUME %

02 May, 2024

54

Week

64.9

Month

54.7

LEGEND

Positive Indicator

Neutral Indicator

Negative Indicator

RESISTANCE AND SUPPORT

2666.97

PIVOT

First Resistance

2691.43

Second Resistance

2712.87

Third Resistance

2737.33

First Support

2645.53

Second Support

2621.07

Third Support

2599.63

Relative Strength Index

57.48

Money Flow Index

57.09

MACD

20.89

MACD Signal

10.04

Average True Range

58.63

Average Directional Index

18.14

Rate of Change (21)

2.67

Rate of Change (125)

38.32

Commodity Channel Index

78

Williams %R

-26.4

BETA

1 Month

0.67

3 Month

0.69

1 Year

0.11

3 Year

-0.1

PRICE CHANGE ANALYSIS

↓ -0.61%

1 Week

Low

High

2635.8

2729.2

↓ -0.2%

1 Month

Low

High

2505.3

2729.2

↑ 6.27%

3 Months

Low

High

2480.65

2744

↑ 39.06%

6 Months

Low

High

1921.5

2744

↑ 61.59%

1 Year

Low

High

1598.45

2744

Indicator Dec 2023 Sep 2023 Jun 2023 Mar 2023 Dec 2022 Sep 2022 Jun 2022 Mar 2022 Dec 2021 Sep 2021 Jun 2021 Graph
Total Qtr Revenue cr 2112.00 2161.00 2132.00 1946.00 1872.00 1939.00 1962.00 1723.00 1625.00 1853.00 1745.00
Operating Expenses Qtr 1422.00 1410.00 1384.00 1342.00 1272.00 1308.00 1268.00 1179.00 1161.00 1182.00 1117.00
Operating Profit Qtr 701.00 736.00 737.00 578.00 585.00 620.00 665.00 483.00 427.00 617.00 578.00
EBIDT Qtr Cr 690.00 751.00 748.00 604.00 600.00 631.00 694.00 544.00 464.00 671.00 628.00
Depreciation Qtr 191.00 192.00 183.00 182.00 156.00 156.00 149.00 147.00 152.00 153.00 150.00
Net Profit Qtr 297.00 327.00 323.00 219.00 229.00 272.00 327.00 221.00 170.00 326.00 274.00
Basic EPS Qtr 8.78 9.65 9.55 6.46 6.78 8.02 19.35 13.08 10.06 19.24 16.21
Indicator Mar 2023 Mar 2022 Mar 2021 Mar 2020 Mar 2019 Graph
Total Revenue Annual 7777.08 6946.49 6568.91 6405.37 6144.44
Operating Expenses Annual Cr 5230.04 4641.56 4258.84 4251.45 4149.45
Operating Profit Annual 2465.16 2100.76 2191.73 1916.99 1613.03
Operating Profit Margin Annual % 31.70 30.24 33.37 29.93 26.25
Total Expenses Annual Cr 6200.06 5480.28 5202.80 5288.60 5209.32
EBIDT Annual Cr 2547.04 2304.93 2310.07 2153.92 1994.99
EBIDT Annual margin % 32.75 33.18 35.17 33.63 32.47
Depreciation 672.34 602.43 609.84 606.66 578.90
PAT Before ExtraOrdinary Items Annual Cr 1051.39 991.45 1137.85 938.51 745.42
Net Profit Annual 1051.39 991.45 1137.85 938.51 745.42
Basic EPS Annual 31.07 58.59 67.24 55.46 44.05
Indicator Mar 2023 Mar 2022 Mar 2021 Mar 2020 Mar 2019 Graph
Total ShareHolders Funds Annual 6455.96 6345.42 6030.10 5120.97 5015.27
Minority Interest Liability Annual Cr - - - - -
Total Non Current Liabilities Annual Cr 3006.82 2383.78 3145.14 3376.02 3924.18
Total Current Liabilities Annual Cr 3409.15 2423.36 2585.80 3387.48 3087.82
Total Capital Plus Liabilities Annual Cr 12871.93 11152.56 11761.04 11884.47 12027.27
Fixed Assets Annual 8669.78 6818.75 7329.35 7733.91 7922.73
Total Non Current Assets Annual 8944.85 7092.51 7619.16 8065.21 8278.32
Total Current Assets Annual 3927.08 4060.05 4141.88 3819.26 3748.95
Total Assets Annual 12871.93 11152.56 11761.04 11884.47 12027.27
Contingent Liabilities plus Commitments Annual Cr 1448.95 1296.42 1155.38 325.37 374.94
Indicator Mar 2023 Mar 2022 Mar 2021 Mar 2020 Mar 2019 Graph
Cash from Operating Activity Annual 2265.41 2140.10 1578.23 1579.90 1231.83
Cash from Investing Activity Annual -2384.07 -159.70 -316.28 269.43 -373.33
Cash from Financing Annual Activity 80.74 -1977.27 -1586.54 -1555.48 -927.58
Net Cash Flow Annual -37.92 3.13 -324.59 293.85 -69.08
Indicator Mar 2023 Mar 2022 Mar 2021 Mar 2020 Mar 2019 Graph
Book Value Per Share Annual 190.75 374.94 356.30 302.59 296.34
ROE Annual % 16.28 15.62 18.86 18.32 14.86
ROCE Annual % 19.81 19.50 18.53 18.20 15.84
Total Debt to Total Equity Annual 0.71 0.53 0.73 0.76 0.89
EBDIT Annual Margin % 33.09 34.18 35.81 34.91 34.62
Indicator Dec 2023 Sep 2023 Jun 2023 Mar 2023 Dec 2022 Sep 2022 Jun 2022 Mar 2022 Dec 2021 Sep 2021 Jun 2021 Graph
Total Qtr Revenue cr 2699.00 2686.00 2625.00 2500.00 2481.00 2307.00 2377.00 2187.00 2156.00 2188.00 2174.00
Operating Expenses Qtr 1863.00 1835.00 1800.00 1764.00 1767.00 1612.00 1635.00 1570.00 1570.00 1477.00 1457.00
Operating Profit Qtr 869.00 825.00 791.00 727.00 724.00 679.00 712.00 561.00 538.00 660.00 677.00
EBIDT Qtr Cr 924.00 851.00 825.00 736.00 714.00 695.00 742.00 132.00 586.00 711.00 717.00
Depreciation Qtr 213.00 201.00 191.00 196.00 193.00 163.00 155.00 162.00 167.00 168.00 165.00
Net Profit Qtr 443.00 386.00 378.00 287.00 283.00 312.00 354.00 -118.00 249.00 316.00 330.00
Basic EPS Qtr 13.10 11.39 11.18 8.48 8.36 9.22 20.90 -6.98 14.75 18.63 19.53
Indicator Mar 2023 Mar 2022 Mar 2021 Mar 2020 Mar 2019 Graph
Total Revenue Annual 9665.29 8704.60 8061.48 8060.61 7729.85
Operating Expenses Annual Cr 6778.10 6076.77 5524.49 5768.95 5689.74
Operating Profit Annual 2842.05 2431.27 2480.08 2170.36 1983.06
Operating Profit Margin Annual % 29.40 27.93 30.76 26.93 25.65
Total Expenses Annual Cr 7818.13 6993.99 6535.22 6874.04 6811.18
EBIDT Annual Cr 2887.19 2627.83 2536.99 2291.66 2040.11
EBIDT Annual margin % 29.87 30.19 31.47 28.43 26.39
Depreciation 706.59 662.16 657.79 654.38 617.69
PAT Before ExtraOrdinary Items Annual Cr 1245.23 777.18 1251.88 1024.72 436.31
Net Profit Annual 1245.23 777.18 1251.88 1024.72 436.28
Basic EPS Annual 36.79 45.93 73.98 60.55 25.78
Indicator Mar 2023 Mar 2022 Mar 2021 Mar 2020 Mar 2019 Graph
Total ShareHolders Funds Annual 6198.07 5952.95 5837.17 4823.22 4724.35
Minority Interest Liability Annual Cr 0.00 0.00 0.00 0.00 0.00
Total Non Current Liabilities Annual Cr 3366.48 2731.80 3345.86 3732.36 4231.25
Total Current Liabilities Annual Cr 5447.30 4415.09 4891.62 5454.16 5165.32
Total Capital Plus Liabilities Annual Cr 15011.85 13099.84 14074.65 14009.74 14120.92
Fixed Assets Annual 8549.35 6792.99 7612.78 7902.96 8030.04
Total Non Current Assets Annual 9682.67 7805.19 8551.43 9028.82 9083.38
Total Current Assets Annual 5329.18 5294.65 5523.22 4980.92 5037.54
Total Assets Annual 15011.85 13099.84 14074.65 14009.74 14120.92
Contingent Liabilities plus Commitments Annual Cr 619.01 505.35 324.34 374.59 392.90
Indicator Mar 2023 Mar 2022 Mar 2021 Mar 2020 Mar 2019 Graph
Cash from Operating Activity Annual 2368.13 1802.99 2010.69 1392.91 1798.08
Cash from Investing Activity Annual -2415.31 -196.63 -449.42 198.61 -241.28
Cash from Financing Annual Activity 77.36 -1781.05 -1656.13 -1549.04 -1314.45
Net Cash Flow Annual 30.18 -174.69 -94.86 42.48 242.35
Indicator Mar 2023 Mar 2022 Mar 2021 Mar 2020 Mar 2019 Graph
Book Value Per Share Annual 183.13 351.75 344.90 284.99 279.15
ROE Annual % 20.09 13.05 21.44 21.24 9.23
ROCE Annual % 22.79 22.63 20.46 19.13 15.88
Total Debt to Total Equity Annual 0.85 0.67 0.83 0.91 1.03
EBDIT Annual Margin % 30.01 30.88 31.69 28.86 26.58
Name Holding Percent Holding Id Pledged % Locked %
KOTAK MAHINDRA TRUSTEE CO LTD A/C KOTAK HEALTHCARE 1.02 75070009 - -
Name Holding Percent Holding Id Pledged % Locked %
TORRENT INVESTMENTS PRIVATE LIMITED 71.25 75070002 0 0
Name Holding Percent Holding Id
KOTAK MAHINDRA TRUSTEE CO LTD A/C KOTAK HEALTHCARE 1.02 75070009
Name Holding Percent Holding Id
Trusts 1.13 75070019
Ex-Date Dividend Amount Dividend Type Record Date Instrument Type
Feb 12, 2024 22 INTERIM Feb 12, 2024 Equity Share
Jun 23, 2023 8 FINAL Jun 23, 2023 Equity Share
Feb 03, 2023 14 INTERIM Feb 03, 2023 Equity Share
Jun 03, 2022 15 SPECIAL Jun 06, 2022 Equity Share
Jun 03, 2022 8 FINAL Jun 06, 2022 Equity Share
Feb 02, 2022 25 INTERIM Feb 03, 2022 Equity Share
Jun 17, 2021 15 FINAL Jun 18, 2021 Equity Share
Feb 15, 2021 20 INTERIM Feb 16, 2021 Equity Share
Mar 18, 2020 15 SPECIAL Mar 19, 2020 Equity Share
Mar 18, 2020 17 INTERIM Mar 19, 2020 Equity Share
Feb 03, 2020 - INTERIM Feb 04, 2020 Equity Share
Jun 13, 2019 4 FINAL Jun 14, 2019 Equity Share
Feb 06, 2019 13 INTERIM Feb 07, 2019 Equity Share
Jun 18, 2018 5 FINAL - Equity Share
Feb 15, 2018 9 INTERIM Feb 19, 2018 Equity Share
Jun 19, 2017 4 FINAL - Equity Share
Feb 10, 2017 10 INTERIM Feb 13, 2017 Equity Share
Mar 16, 2016 15 INTERIM Mar 17, 2016 Equity Share
Feb 11, 2016 20 INTERIM Feb 12, 2016 Equity Share
Jun 15, 2015 6.25 FINAL - Equity Share
Feb 02, 2015 5 INTERIM Feb 03, 2015 Equity Share
Jun 16, 2014 5 FINAL - Equity Share
Jan 24, 2014 5 INTERIM Jan 27, 2014 Equity Share
Jun 10, 2013 17 FINAL - Equity Share
Feb 01, 2013 6 INTERIM Feb 04, 2013 Equity Share
Jun 11, 2012 2.5 FINAL - Equity Share
Jan 27, 2012 6 INTERIM Jan 30, 2012 Equity Share
Jun 06, 2011 8 FINAL - Equity Share
Jun 04, 2010 6 FINAL - Equity Share
Jun 08, 2009 4 FINAL - Equity Share
Jun 19, 2008 3.5 FINAL - Equity Share
Mar 23, 2007 3 INTERIM Mar 26, 2007 Equity Share
Jun 15, 2006 2.5 FINAL - Equity Share
Jun 09, 2005 8 FINAL - Equity Share
Jun 17, 2004 8 FINAL - Equity Share
Jun 10, 2003 8 FINAL - Equity Share
Jun 05, 2002 - FINAL - Equity Share
May 28, 2001 - FINAL - Equity Share
Ex-Date Split Ratio Record Date
Feb 20, 2006 10:5 2006-02-27
Ex-Date Purpose Notes
Feb 02, 2024 Quarterly Results & Interim Dividend -
Oct 23, 2023 Quarterly Results -
Aug 07, 2023 Quarterly Results -
May 30, 2023 Audited Results & Final Dividend -
Jan 25, 2023 Quarterly Results & Interim Dividend -
Oct 21, 2022 Quarterly Results -
Jul 29, 2022 Quarterly Results -
May 25, 2022 Audited Results, Dividend & Bonus issue -
Jan 25, 2022 Quarterly Results & Interim Dividend -
Oct 26, 2021 Quarterly Results -
Jul 27, 2021 Quarterly Results -
May 18, 2021 Audited Results & Final Dividend Inter alia, Taking enabling resolutions for raising of funds by issue of Equity Shares including Convertible Bonds / Debentures through Qualified Institutional Placement (QIP) etc.
Feb 08, 2021 Quarterly Results & Interim Dividend -
Oct 26, 2020 Quarterly Results -
Jul 30, 2020 Quarterly Results -
May 26, 2020 Audited Results -
Mar 11, 2020 Interim Dividend -
Jan 27, 2020 Quarterly Results & Interim Dividend inter alia, Taking enabling resolutions for raising of funds by issue of Equity Shares including Convertible Bonds / Debentures through Qualified Institutional Placement (QIP) and / or any other modes
Oct 23, 2019 Quarterly Results -
Jul 23, 2019 Quarterly Results -
May 20, 2019 Audited Results & Final Dividend -
Jan 30, 2019 Quarterly Results & Interim Dividend -
Nov 03, 2018 Quarterly Results -
Aug 02, 2018 Quarterly Results -
May 30, 2018 Audited Results & Final Dividend -
Feb 08, 2018 Quarterly Results & Interim Dividend -
Jan 25, 2018 Others -
Nov 03, 2017 Quarterly Results -
Jul 31, 2017 Quarterly Results -
May 26, 2017 Audited Results & Final Dividend -
Feb 03, 2017 Quarterly Results & Interim Dividend -
Oct 26, 2016 Quarterly Results -
Jul 27, 2016 Quarterly Results -
May 23, 2016 Others The Board did not recommend distribution of any further dividend.
Mar 23, 2016 Others Inter-alia the proposal for raising of funds by way of: a) Issue of Equity shares including Convertible Bonds/Debentures through Qualified Institutional Placements (QIP) and/ or Depository Receipts.
Mar 09, 2016 Second Interim Dividend -
Feb 04, 2016 Quarterly Results & Interim Dividend -
Oct 29, 2015 Quarterly Results -
Jul 27, 2015 Quarterly Results -
May 15, 2015 Audited Results & Final Dividend -
Jan 28, 2015 Quarterly Results & Interim Dividend -
Nov 05, 2014 Quarterly Results -
Jul 30, 2014 Quarterly Results -
May 09, 2014 Audited Results & Final Dividend -
Jan 21, 2014 Quarterly Results & Interim Dividend -
Oct 30, 2013 Quarterly Results -
Jul 26, 2013 Quarterly Results -
May 30, 2013 Audited Results & Final Dividend -
Jan 29, 2013 Quarterly Results & Interim Dividend -
Oct 26, 2012 Quarterly Results -
Jul 23, 2012 Quarterly Results -
May 18, 2012 Audited Results & Final Dividend -
Jan 23, 2012 Quarterly Results & Interim Dividend -
Oct 18, 2011 Quarterly Results -
Jul 30, 2011 Quarterly Results -
May 28, 2011 Audited Results & Dividend -
Jan 19, 2011 Quarterly Results -
Oct 23, 2010 Quarterly Results -
Jul 30, 2010 Quarterly Results -
May 06, 2010 Audited Results & Dividend -
Jan 27, 2010 Quarterly Results -
Oct 31, 2009 Quarterly Results -
Jul 29, 2009 Quarterly Results -
May 15, 2009 Audited Results & Dividend -
Jan 28, 2009 Quarterly Results -
Oct 24, 2008 Quarterly Results -
May 06, 2008 Audited Results & Dividend -
Jan 31, 2008 Quarterly Results -
Oct 30, 2007 Quarterly Results -
Jul 31, 2007 Quarterly Results -
May 23, 2007 Audited Results -
Mar 17, 2007 Interim Dividend -
Jan 24, 2007 Quarterly Results -
Oct 28, 2006 Quarterly Results -
Jul 21, 2006 Quarterly Results -
May 23, 2006 Accounts & Dividend -
Jan 25, 2006 Quarterly Results -
Dec 15, 2005 Stock Split & Bonus Issue -
Oct 26, 2005 Quarterly Results -
Jul 26, 2005 Quarterly Results -
May 13, 2005 Dividend & Accounts -
Jan 21, 2005 Quarterly Results -
Aug 17, 2004 Quarterly Results -
Jun 10, 2004 Dividend & Accounts -
Jan 27, 2004 Quarterly Results -
Oct 23, 2003 Quarterly Results -
Jul 31, 2003 Quarterly Results -
Jun 05, 2003 Accounts (Revised)
Jan 23, 2003 Quarterly Results -
Oct 23, 2002 Accounts -
Jul 22, 2002 Quarterly Results -
May 13, 2002 Accounts -
Mar 09, 2002 Interim Dividend -
Jan 24, 2002 Quarterly Results -
Oct 30, 2001 Quarterly Results -
Jul 23, 2001 Quarterly Results -
May 25, 2001 Dividend & Accounts -
Jan 24, 2001 Quarterly Results -
Oct 19, 2000 Quarterly Results -
Jul 24, 2000 Quarterly Results -
May 10, 2000 Accounts & Final Dividend -
Mar 27, 2000 Interim Dividend -
Jan 24, 2000 Quarterly Results -
Jul 23, 1999 Quarterly Results -
May 26, 1999 Accounts -
Jan 22, 1999 Quarterly Results -
Oct 29, 1998 Quarterly Results -
Jul 27, 1998 Quaterly Results -
Jun 20, 1998 Accounts & Dividend -
Nov 21, 1997 Half Yearly Results -
Jun 21, 1997 Accounts & Dividend. -
Ex-Date Bonus Ratio Record Date
Jul 08, 2022 1:1 2022-07-11
Jul 23, 2013 1:1 2013-07-24
Feb 20, 2006 1:1 2006-02-27
Bigul
02 May 2024

TORRENT PHARMACEUTICALS LTD. - 500420 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate

 Intimation of Loss of Share Certificate
Bigul
02 May 2024

TORRENT PHARMACEUTICALS LTD. - 500420 - Disclosure Under Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015

 Disclosure under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
Bigul
30 Apr 2024

TORRENT PHARMACEUTICALS LTD. - 500420 - Disclosure Under Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015

 Disclosure under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
Bigul
23 Apr 2024

TORRENT PHARMACEUTICALS LTD. - 500420 - Disclosure Under Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015

 Disclosure under Regulation 30 of SEBI (LODR) Regulations, 2015
Bigul
19 Apr 2024

TORRENT PHARMACEUTICALS LTD. - 500420 - Disclosure Under Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015

 Disclosure under Regulation 30 of SEBI (Listing Obligation and disclosure Requirements) Regulations, 2015
Bigul
12 Apr 2024

TORRENT PHARMACEUTICALS LTD. - 500420 - Compliance Certificate Under Regulation 40(9) Of SEBI (LODR) Regulations, 2015

 Compliance Certificate u/r 40(9) of SEBI (LODR) Regulations, 2015
Bigul
09 Apr 2024

TORRENT PHARMACEUTICALS LTD. - 500420 - Conclusion Time Of The 50Th Annual General Meeting Of The Company

 Conclusion time of the 50th Annual General Meeting of the Company
Bigul
08 Apr 2024

TORRENT PHARMACEUTICALS LTD. - 500420 - Disclosure Under Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015

 Disclosure u/r 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
Bigul
04 Apr 2024

TORRENT PHARMACEUTICALS LTD. - 500420 - Submission Of Compliance Certificate Under Regulation 7(3) Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015

 Compliance Certificate under Regulation 7(3)
Bigul
01 Apr 2024

TORRENT PHARMACEUTICALS LTD. - 500420 - Announcement under Regulation 30 (LODR)-Cessation

 Intimation of Cessation of Directors of the Company
See all News

FAQs

The latest market price of Torrent Pharmaceuticals Ltd. on NSE was Rs. 2670.00 as of today.

The opening share price of Torrent Pharmaceuticals Ltd. was Rs. 2652.80 as of today.

The 52-week high share price of Torrent Pharmaceuticals Ltd. was Rs. 2744.00.

The 52 week low share price of Torrent Pharmaceuticals Ltd. was Rs. 1598.40.

Torrent Pharmaceuticals Ltd. has a market cap of Rs. 90364.90 crore as of today. Please refer to the Fundamentals section for further details.

The PE ratio of Torrent Pharmaceuticals Ltd. is 0.80. Please refer to the Fundamentals section for further details.

The operating revenue for Torrent Pharmaceuticals Ltd. in the last FY was Rs.  10474.00 crore. Please refer to the Financials section for further details.

The Net Profit for Torrent Pharmaceuticals Ltd. in the last FY was Rs. 1494.00 crore. Please refer to the Financials section for further details.

Please refer to Stock Ants, Bigul’s Community Access platform that aggregates tips and research from experts and provides real-time tracking to help investors validate, discover new investment ideas, and make informed decisions. Click here to learn more.

Please refer to Stock Ants, Bigul’s Community Access platform that aggregates tips and research from experts and provides real-time tracking to help investors validate, discover new investment ideas, and make informed decisions. Click here to learn more.

The latest dividend declared by Torrent Pharmaceuticals Ltd. was on 2024-02-12 for Rs. 22 per share. According to today’s share price, the dividend yield of Torrent Pharmaceuticals Ltd. stands at 1.10. Please refer to the Corporate Actions section for further details.

The latest bonus issue declared by Torrent Pharmaceuticals Ltd. was as of 2022-07-08. The bonus ratio declared in this issue was 1:1. Please refer to the Corporate Actions section for further details.

The latest split issue declared by Torrent Pharmaceuticals Ltd. was as of 2006-02-20. The split ratio declared in this issue was 10:5. Please refer to the Corporate Actions section for further details.

Please refer to Bigul Traders Corner, One Stop destination for different algo and non-algo trading strategies and tools meant for investors, traders, and strategists. Our qualified experts with rich experience in broking, financial analysis, and software development designed it in-house. Click here to learn more.

Please refer to JARVIS, which is Bigul’s AI Portfolio Manager Tool that uses artificial intelligence algorithms to make investment decisions in a portfolio. Click here to learn more.

Please refer to the News section for the latest news about Torrent Pharmaceuticals Ltd..

Close

Let's Open Free Demat Account